SmPC- Telmisartan/Hydrochlorothiazide 80mg/12.5mg Tablets: Change history
View Summary of Product Characteristics (SmPC- Telmisartan/Hydrochlorothiazide 80mg/12.5mg Tablets)
Last updated on this site: 13 May 2025
Update to SmPC sections 4.4, 4.8 and PIL sections 2 and 4 in line with PRAC recommendations (EPITT No 20104) for intestinal angioedema.
View Summary of Product Characteristics (SmPC- Telmisartan/Hydrochlorothiazide 80mg/12.5mg Tablets)
Last updated on this site: 13 May 2025
Update to SmPC sections 4.4, 4.8 and PIL sections 2 and 4 in line with PRAC recommendations (EPITT No 20104) for intestinal angioedema.
-
Changes: (Updated: 13 May 2025)
Update to SmPC sections 4.4, 4.8 and PIL sections 2 and 4 in line with PRAC recommendations (EPITT No 20104) for intestinal angioedema.
-
Changes: (Updated: 14 Apr 2023)
Variation description: Type IB (C.I.3.z) variation application to update SmPC section 5.3 for `incresed risk of skin cancer' as per CMDh minutes for the meeting updated on 8-10 November 2022.
SmPC sections updated: 5.3, 9, 10.
-
Changes: (Updated: 22 Sep 2022)
initial upload